You searched for "bleeding"
Vitreomacular traction: natural course vs. vitrectomy vs. ocriplasmin
Over time, the vitreous gel completely separates from the retina in a process known as a posterior vitreous detachment (PVD). In some instances, however, the vitreous does not detach entirely and remains adherent to the macula. The term vitreomacular traction...Anisometropia following cataract surgery and its non-surgical treatment
The desired result of cataract surgery is improved visual acuity without the use of spectacles. In practice most patients following initial cataract extraction are likely to be symptomatic of anisometropia giving rise to prismatic effects (anisophoria) and unequal retinal image...The results of the last survey Dec21
Consent is a hot topic at the moment and the publication of the GMC Guidance on Consent [1] has rightfully refocussed our attention on it. Consent practices vary wildly and have been the subject of many of these surveys. Once...New vision programme will test the sight of 47,500 rural Zambians
Last month, VisionSpring, Live Well (affiliated with CARE International) and the Council of Churches Zambia (CCZ) officially launched the Reading Glasses for Improved Livelihoods (RGIL) programme in Zambia.Minister for equalities backs Sight Scotland’s push to break down accessibility barriers in Scottish venues
Equalities Minister Kaukab Stewart recently met with Sight Scotland’s Policy Group to discuss the importance of improving access and inclusion in Scotland’s venues. She stressed that everyone should have the freedom to enjoy life and visit places of their choice,...Scotland’s young blind voices boosted by new funding
A youth-led forum for blind and partially sighted young people has secured vital funding, enabling a new period of opportunity for young blind and partially sighted people across Scotland. Haggeye, operated by national sight loss charity, RNIB Scotland, will expand...Shifting the paradigm of managing patients in medical retina: how real-world data can help us to improve clinical practice
The ophthalmic subspecialty of ‘medical retina’ has undergone dramatic changes in recent years. With the introduction of ranibizumab (Lucentis, Novartis), a specialty formerly dominated by laser-based therapies has been transformed to become, in large part, pharmacotherapy-based. To date, these pharmacotherapies...
Intravitreal ranibizumab for the treatment of myopic CNV
The authors conducted a prospective study. Sixty-four patients (65 eyes) attended the 12-month follow-up examination. The mean patient age was 47.8 years. Fifty-five patients (86.0%) were females. All patients had pathologic myopia (a spherical equivalent of more than − 6.0...
